0001144204-15-038692.txt : 20150623 0001144204-15-038692.hdr.sgml : 20150623 20150623165057 ACCESSION NUMBER: 0001144204-15-038692 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150618 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150623 DATE AS OF CHANGE: 20150623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RIDGEFIELD ACQUISITION CORP CENTRAL INDEX KEY: 0000812152 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 840922701 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16335 FILM NUMBER: 15947510 BUSINESS ADDRESS: STREET 1: 900 THIRD AVE STREET 2: SUITE 201 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 3033680401 MAIL ADDRESS: STREET 1: 900 THIRD AVE STREET 2: SUITE 201 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BIO MEDICAL AUTOMATION INC DATE OF NAME CHANGE: 19990323 FORMER COMPANY: FORMER CONFORMED NAME: OZO DIVERSIFIED AUTOMATION INC /CO/ DATE OF NAME CHANGE: 19920703 8-K 1 v413900_8-k.htm FORM 8-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

CURRENT REPORT

 

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 18, 2015

 

 

Ridgefield Acquisition Corp.

 

(Exact Name of Registrant as Specified in Charter)

 

Nevada   0-16335   84-0922701

(State or other Jurisdiction of Incorporation)

  (Commission File No.)  

(I.R.S. Employer Identification Number)

 

 

31248 Oak Crest Drive, Suite 110, Westlake Village, California 91361

 

(Address of Principal Executive Office) (Zip Code)

 

 

(805) 416-7054

 

(Registrant's telephone number including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 5.02.Departure of Directors or Certain Officers; Election Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective June 18, 2015, Dr. Kenneth S. Schwartz resigned from the Board of Directors of Ridgefield Acquisition Corp. (the “Company”). Dr. Schwartz resigned for personal reasons. There was no disagreement between Dr. Schwartz and the Company. A copy of Dr. Schwartz’s resignation letter is attached to this Current Report on Form 8-K as Exhibit 17.

 

The Company is grateful to Dr. Schwartz for his services and wishes him success in all of his future endeavors.

 

Section 9 - Financial Statements and Exhibits

 

Item 9.01Financial Statements and Exhibits.

 

(c) Exhibits.

 

The following Exhibits are hereby filed as part of this Current Report on Form 8-K:

 

Exhibit

 

17Letter of Resignation of Dr. Kenneth S. Schwartz.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Ridgefield Acquisition Corp. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: June 23, 2015

 

  Ridgefield Acquisition Corp.
  (Registrant)
   
  By: /s/ STEVEN N. BRONSON
    Steven N. Bronson,
    CEO and President
     

 

 

 

 

 

EX-17 2 v413900_ex17.htm EXHIBIT 17

 

 

Exhibit 17

 

Dr. Kenneth S. Schwartz

26 Navajo Road

Manalapan, NJ 07726

 

To: Ridgefield Acquisition Corporation

 

Please accept my resignation from the Board of Directors as of June 18, 2015, for personal reasons.

 

Sincerely,

 

/S/ Dr. Kenneth S. Schwartz